Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery
Durvalumab shows promising results in trial led by London-based Institute of Cancer Research
Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery A trial led by the Institute of Cancer Research in London has shown promising results for the drug durvalumab. This treatment offers a chance for bladder cancer patients to avoid surgery. The drug’s success indicates a potential shift in treatment approaches for this disease.
- Durvalumab shows promising results in a trial.
- The trial was led by the Institute of Cancer Research in London.
- The drug may spare bladder cancer patients from surgery.
No comments yet.
Write a comment